Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015

Pseudomonas aeruginosa is intrinsically resistant to many antimicrobial drugs, making carbapenems crucial in clinical management. During July–October 2015 in the United States, we piloted laboratory-based surveillance for carbapenem-resistant P. aeruginosa (CRPA) at sentinel facilities in Georgia, N...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Emerg Infect Dis
Κύριοι συγγραφείς: Walters, Maroya Spalding, Grass, Julian E., Bulens, Sandra N., Hancock, Emily B., Phipps, Erin C., Muleta, Daniel, Mounsey, Jackie, Kainer, Marion A., Concannon, Cathleen, Dumyati, Ghinwa, Bower, Chris, Jacob, Jesse, Cassidy, P. Maureen, Beldavs, Zintars, Culbreath, Karissa, Phillips, Walter E., Hardy, Dwight J., Vargas, Roberto L., Oethinger, Margret, Ansari, Uzma, Stanton, Richard, Albrecht, Valerie, Halpin, Alison Laufer, Karlsson, Maria, Rasheed, J. Kamile, Kallen, Alexander
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Centers for Disease Control and Prevention 2019
Θέματα:
Synopsis
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590762/
https://ncbi.nlm.nih.gov/pubmed/31211681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2507.181200
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια